Lucia Sue Selected Research

Alzheimer Disease (Alzheimer's Disease)

7/2023	Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer's Disease.
1/2017	Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway.
7/2013	Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
3/2013	BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.
1/2011	Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.
4/2009	Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
5/2008	In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.
12/2006	Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
3/2004	Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
1/2003	Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucia Sue Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 07/2023 - 09/2002
3	Dementia (Dementias) 01/2011 - 12/2006
3	Amyloid Plaque 04/2010 - 05/2008
2	Cognitive Dysfunction 01/2011 - 12/2006
1	Type 2 Diabetes Mellitus (MODY) 07/2013
1	Myoclonus (Nocturnal Myoclonus) 07/2011
1	Parkinson Disease (Parkinson's Disease) 07/2011
1	Amyloid angiopathy 04/2010
1	Movement Disorders (Movement Disorder) 05/2008
1	Hypoxia (Hypoxemia) 07/2004
1	Pathologic Constriction (Stenosis) 07/2004
1	Ischemia 07/2004
1	Tauopathies 07/2003

Drug/Important Bio-Agent (IBA)

4	Amyloid (Amyloid Fibrils)IBA 04/2010 - 07/2004
3	Apolipoproteins E (ApoE)IBA 07/2013 - 04/2010
2	Amyloid beta-PeptidesIBA 05/2008 - 03/2004
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2004 - 01/2003
1	RNA (Ribonucleic Acid)IBA 07/2023
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	SynucleinsIBA 07/2011
1	alpha-SynucleinIBA 07/2011
1	CytokinesIBA 01/2011
1	ApolipoproteinsIBA 04/2010
1	dicyanmethane (malononitrile)IBA 04/2009
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2008
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2006
1	SilverIBA 07/2003
1	Peptides (Polypeptides)IBA 09/2002
1	CholesterolIBA 09/2002
1	Myelin ProteinsIBA 09/2002